Merit Medical (MMSI) | Financial Analysis & Statements
Merit Medical Systems, Inc. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
393.9M
Gross Profit
195.4M
49.59%
Operating Income
54.0M
13.70%
Net Income
38.0M
9.65%
EPS (Diluted)
$0.63
Balance Sheet Metrics
Total Assets
2.7B
Total Liabilities
1.1B
Shareholders Equity
1.6B
Debt to Equity
0.70
Cash Flow Metrics
Operating Cash Flow
81.3M
Free Cash Flow
73.3M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Merit Medical Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.5B | 1.4B | 1.3B | 1.2B | 1.1B |
| Cost of Goods Sold | 777.6M | 713.2M | 673.5M | 631.9M | 589.4M |
| Gross Profit | 738.3M | 643.3M | 583.9M | 519.1M | 485.3M |
| Gross Margin % | 48.7% | 47.4% | 46.4% | 45.1% | 45.2% |
| Operating Expenses | |||||
| Research & Development | 97.4M | 87.5M | 82.7M | 75.5M | 71.2M |
| Selling, General & Administrative | 455.2M | 399.7M | 373.7M | 342.5M | 335.7M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 552.6M | 487.2M | 456.4M | 418.0M | 406.9M |
| Operating Income | 185.7M | 156.1M | 127.5M | 101.1M | 78.4M |
| Operating Margin % | 12.3% | 11.5% | 10.1% | 8.8% | 7.3% |
| Non-Operating Items | |||||
| Interest Income | 15.1M | 26.2M | 2.5M | 439.0K | 769.0K |
| Interest Expense | 26.5M | 31.2M | 15.5M | 6.3M | 5.3M |
| Other Non-Operating Income | -3.4M | -1.2M | -2.3M | -12.5M | -20.0M |
| Pre-tax Income | 170.9M | 150.0M | 112.1M | 82.6M | 53.9M |
| Income Tax | 42.4M | 29.6M | 17.7M | 8.1M | 5.5M |
| Effective Tax Rate % | 24.8% | 19.8% | 15.8% | 9.8% | 10.1% |
| Net Income | 128.5M | 120.4M | 94.4M | 74.5M | 48.5M |
| Net Margin % | 8.5% | 8.9% | 7.5% | 6.5% | 4.5% |
| Key Metrics | |||||
| EBITDA | 333.0M | 296.4M | 232.4M | 194.7M | 172.4M |
| EPS (Basic) | $2.17 | $2.07 | $1.64 | $1.31 | $0.86 |
| EPS (Diluted) | $2.13 | $2.03 | $1.62 | $1.29 | $0.84 |
| Basic Shares Outstanding | 59158000 | 58218000 | 57593000 | 56806000 | 56145000 |
| Diluted Shares Outstanding | 59158000 | 58218000 | 57593000 | 56806000 | 56145000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Merit Medical Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 446.4M | 376.7M | 587.0M | 58.4M | 67.8M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 203.7M | 190.2M | 177.9M | 164.7M | 152.3M |
| Inventory | 333.7M | 306.1M | 303.9M | 266.0M | 221.9M |
| Other Current Assets | 31.5M | 28.5M | 24.3M | 22.3M | 16.1M |
| Total Current Assets | 1.0B | 923.8M | 1.1B | 529.1M | 482.2M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 452.9M | 406.4M | 380.0M | 364.4M | 343.9M |
| Goodwill | 1.6B | 1.4B | 1.1B | 995.5M | 1.0B |
| Intangible Assets | 537.7M | 498.3M | 325.9M | 275.9M | 319.3M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 40.3M | 49.1M | 39.8M | 33.0M | 30.4M |
| Total Non-Current Assets | 1.6B | 1.5B | 1.2B | 1.1B | 1.2B |
| Total Assets | 2.7B | 2.4B | 2.3B | 1.7B | 1.6B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 60.6M | 68.5M | 65.9M | 68.5M | 55.6M |
| Short-term Debt | 10.9M | 10.3M | 12.1M | 22.3M | 19.1M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 239.8M | 216.4M | 203.6M | 220.6M | 236.3M |
| Non-Current Liabilities | |||||
| Long-term Debt | 810.7M | 784.3M | 879.3M | 246.5M | 295.9M |
| Deferred Tax Liabilities | 19.7M | 240.0K | 5.5M | 18.5M | 31.5M |
| Other Non-Current Liabilities | 12.6M | 17.6M | 15.7M | 16.6M | 24.5M |
| Total Non-Current Liabilities | 861.9M | 822.8M | 919.7M | 298.9M | 372.2M |
| Total Liabilities | 1.1B | 1.0B | 1.1B | 519.6M | 608.5M |
| Equity | |||||
| Common Stock | 763.9M | 703.2M | 638.2M | 675.2M | 641.5M |
| Retained Earnings | 824.0M | 695.5M | 575.2M | 480.8M | 406.3M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.6B | 1.4B | 1.2B | 1.1B | 1.0B |
| Key Metrics | |||||
| Total Debt | 821.6M | 794.7M | 891.4M | 268.8M | 315.0M |
| Working Capital | 800.4M | 707.4M | 904.9M | 308.4M | 245.9M |
Balance Sheet Composition
Merit Medical Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 128.5M | 120.4M | 94.4M | 74.5M | 48.5M |
| Depreciation & Amortization | 134.6M | 114.7M | 101.3M | 92.2M | 95.8M |
| Stock-Based Compensation | 43.5M | 28.5M | 21.3M | 18.0M | 16.1M |
| Working Capital Changes | -38.7M | -41.3M | -67.0M | -57.4M | -50.8M |
| Operating Cash Flow | 279.6M | 214.5M | 142.2M | 124.2M | 108.6M |
| Investing Activities | |||||
| Capital Expenditures | - | 5.0K | 201.0K | 65.0K | 1.0M |
| Acquisitions | -144.8M | -320.2M | -137.8M | -9.3M | -7.2M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -162.6M | -330.6M | -138.6M | -9.2M | -6.4M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 0 | 0 | 1.2B | 215.2M | 98.4M |
| Debt Repayment | 0 | -99.1M | -579.6M | -260.1M | -206.9M |
| Financing Cash Flow | 16.0M | -60.0M | 559.3M | -60.3M | -98.4M |
| Free Cash Flow | 212.5M | 182.8M | 108.4M | 66.1M | 116.5M |
| Net Change in Cash | 133.1M | -176.1M | 562.8M | 54.8M | 3.8M |
Cash Flow Trend
Merit Medical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
32.73
Forward P/E
15.88
Price to Book
2.62
Price to Sales
2.74
PEG Ratio
0.98
Profitability Ratios
Profit Margin
8.48%
Operating Margin
15.79%
Return on Equity
8.67%
Return on Assets
4.75%
Financial Health
Current Ratio
4.34
Debt to Equity
51.86
Beta
0.64
Per Share Data
EPS (TTM)
$2.13
Book Value per Share
$26.66
Revenue per Share
$25.63
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| MMSI | 4.1B | 32.73 | 2.62 | 8.67% | 8.48% | 51.86 |
| Intuitive Surgical | 170.1B | 54.97 | 8.99 | 16.69% | 28.38% | 0.95 |
| Becton, Dickinson | 56.1B | 25.40 | 1.75 | 6.96% | 8.01% | 77.28 |
| Baxter International | 9.4B | 86.31 | 1.54 | -13.71% | -8.51% | 160.28 |
| AptarGroup | 8.0B | 21.10 | 2.99 | 15.10% | 10.40% | 57.10 |
| Repligen | 7.5B | 154.30 | 3.55 | 2.40% | 6.62% | 32.76 |
Financial data is updated regularly. All figures are in the company's reporting currency.






